Total buying$00 buys
ABEO
ABEONA THERAPEUTICS INC.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$208k4 sells
Net open-market−$208kBuying minus selling
Active insiders4Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Sep 30, 2026
Open-market transaction mix · 4 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 4 | 0 | $0 | $208k | -$208k |
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- SV-$101.1k
- VW-$47.4k
- OM-$34.7k
- VM-$25.3k
ABEO transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
ABEOABEONA THERAPEUTICS INC. | Seshadri VishwasCEO | S · saleSEC filing ↗ | -$101kView disclosure → | |
ABEOABEONA THERAPEUTICS INC. | Vazzano Joseph WalterCFO | S · saleSEC filing ↗ | -$47.3kView disclosure → | |
ABEOABEONA THERAPEUTICS INC. | O'Malley Brendan M.SVP · CLO | S · saleSEC filing ↗ | -$34.6kView disclosure → | |
ABEOABEONA THERAPEUTICS INC. | Vasanthavada MadhavCCO | S · saleSEC filing ↗ | -$25.2kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 4 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period4transactionstxns
- S · Open-market sells · dominant4 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesCCO1
Chief executive officer1
Chief financial officer1
CLO1
SVP1
Reported Holdings After
Separated by insider, security, and ownership type
Vasanthavada MadhavCommon Stock · Direct
285,721Sep 29, 2026
O'Malley Brendan M.Common Stock · Direct
421,226Sep 29, 2026
Vazzano Joseph WalterCommon Stock · Direct
482,888Sep 29, 2026
Seshadri VishwasCommon Stock · Direct
1,286,500Sep 29, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
ABEONA THERAPEUTICS INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at ABEONA THERAPEUTICS INC.?
Seshadri Vishwas, Vazzano Joseph Walter, O'Malley Brendan M., Vasanthavada Madhav.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Seshadri Vishwas reported a sale on Sep 29, 2026 valued at $101k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $208,430.59. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.